Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joan S Chmiel

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
American Journal of Epidemiology|February 4, 2011
Limitation of inverse probability-of-censoring weights in estimating survival in the presence of strong selection biasChanelle J Howe, Stephen R Cole, Joan S Chmiel, et al.
AIDS (London, England)|August 13, 2002
Durability and predictors of success of highly active antiretroviral therapy for ambulatory HIV-infected patientsFrank J Palella, Joan S Chmiel, Anne C Moorman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 19, 2015
Disparities in Initiation of Combination Antiretroviral Treatment and in Virologic Suppression Among Patients in the HIV Outpatient Study, 2000-2013Richard M Novak, Rachel L D Hart, Joan S Chmiel, et al.
JAMA Network Open|May 5, 2020
Association of Long-term Strenuous Physical Activity and Extensive Sitting With Incident Radiographic Knee OsteoarthritisAlison H Chang, Jungwha Julia Lee, Joan S Chmiel, et al.
Journal of General Internal Medicine|April 23, 2013
Polypharmacy and risk of antiretroviral drug interactions among the aging HIV-infected populationCarol Holtzman, Carl Armon, Ellen Tedaldi, et al.
American Journal of Epidemiology|November 26, 2009
Using marginal structural measurement-error models to estimate the long-term effect of antiretroviral therapy on incident AIDS or deathStephen R Cole, Lisa P Jacobson, Phyllis C Tien, et al.
Statistics in Medicine|October 20, 2004
Accounting for leadtime in cohort studies: evaluating when to initiate HIV therapiesStephen R Cole, Rui Li, Kathryn Anastos, et al.
Open Forum Infectious Diseases|June 16, 2017
Incidence of Hepatitis C Virus Infection in the Human Immunodeficiency Virus Outpatient Study Cohort, 2000-2013Taraz Samandari, Ellen Tedaldi, Carl Armon, et al.
The Clinical Journal of Pain|May 5, 2011
Factors associated with initiation of prolonged analgesic use among patients in the HIV Outpatient Study (HOPS)John Koeppe, Kenneth Lichtenstein, Carl Armon, et al.
HIV Clinical Trials|July 2, 2015
Long-term immunologic and virologic responses on raltegravir-containing regimens among ART-experienced participants in the HIV Outpatient StudyKate Buchacz, Ryan Wiegand, Carl Armon, et al.
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
American Journal of Epidemiology|February 4, 2011
Limitation of inverse probability-of-censoring weights in estimating survival in the presence of strong selection biasChanelle J Howe, Stephen R Cole, Joan S Chmiel, et al.
AIDS (London, England)|August 13, 2002
Durability and predictors of success of highly active antiretroviral therapy for ambulatory HIV-infected patientsFrank J Palella, Joan S Chmiel, Anne C Moorman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 19, 2015
Disparities in Initiation of Combination Antiretroviral Treatment and in Virologic Suppression Among Patients in the HIV Outpatient Study, 2000-2013Richard M Novak, Rachel L D Hart, Joan S Chmiel, et al.
JAMA Network Open|May 5, 2020
Association of Long-term Strenuous Physical Activity and Extensive Sitting With Incident Radiographic Knee OsteoarthritisAlison H Chang, Jungwha Julia Lee, Joan S Chmiel, et al.
Journal of General Internal Medicine|April 23, 2013
Polypharmacy and risk of antiretroviral drug interactions among the aging HIV-infected populationCarol Holtzman, Carl Armon, Ellen Tedaldi, et al.
American Journal of Epidemiology|November 26, 2009
Using marginal structural measurement-error models to estimate the long-term effect of antiretroviral therapy on incident AIDS or deathStephen R Cole, Lisa P Jacobson, Phyllis C Tien, et al.
Statistics in Medicine|October 20, 2004
Accounting for leadtime in cohort studies: evaluating when to initiate HIV therapiesStephen R Cole, Rui Li, Kathryn Anastos, et al.
Open Forum Infectious Diseases|June 16, 2017
Incidence of Hepatitis C Virus Infection in the Human Immunodeficiency Virus Outpatient Study Cohort, 2000-2013Taraz Samandari, Ellen Tedaldi, Carl Armon, et al.
The Clinical Journal of Pain|May 5, 2011
Factors associated with initiation of prolonged analgesic use among patients in the HIV Outpatient Study (HOPS)John Koeppe, Kenneth Lichtenstein, Carl Armon, et al.
HIV Clinical Trials|July 2, 2015
Long-term immunologic and virologic responses on raltegravir-containing regimens among ART-experienced participants in the HIV Outpatient StudyKate Buchacz, Ryan Wiegand, Carl Armon, et al.
Pageof 10